Cargando…
Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth
OBJECTIVE: To analyze the effect of sirolimus and sunitinib in blocking the tumor growth and to evaluate the expressions of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor-2 (HER2/neu) after treated with sirolimus and sunitinib. METHODS: Thirty-two fem...
Autores principales: | Jaffar, Nurul Fathiyatul Nabila, Sakri, Muhammad Shahidan Muhammad, Jaafar, Hasnan, Abdul Rahman, Wan Faiziah Wan, Din, Tengku Ahmad Damitri Al-Astani Tengku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798166/ https://www.ncbi.nlm.nih.gov/pubmed/33112549 http://dx.doi.org/10.31557/APJCP.2020.21.10.2919 |
Ejemplares similares
-
Rapamycin as a potent and selective inhibitor of vascular endothelial growth
factor receptor in breast carcinoma
por: Muhammad Sakri, Muhammad Shahidan, et al.
Publicado: (2022) -
The Unique Biology behind the Early Onset of Breast Cancer
por: Siddig, Alaa, et al.
Publicado: (2021) -
Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
por: Dass, Sylvia Annabel, et al.
Publicado: (2021) -
Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses
por: Siddig, Alaa, et al.
Publicado: (2023) -
Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers
por: Jusoh, A. Rashid, et al.
Publicado: (2021)